Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells

被引:58
|
作者
Kikuchi, H
Iizuka, R
Sugiyama, S
Gon, G
Mori, H
Arai, M
Mizumoto, K
ImajohOhmi, S
机构
[1] UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN
[2] KITASATO UNIV,SCH PHARMACEUT SCI,TOKYO 108,JAPAN
[3] JIKEI UNIV,SCH MED,TOKYO,JAPAN
[4] NATL INST AGROBIOL RESOURCES,IBARAKI,OSAKA,JAPAN
关键词
apoptosis; cell growth; cell death; Fas antigen; monocyte/macrophage;
D O I
10.1002/jlb.60.6.778
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferon-gamma (IFN-gamma), vitamin D-3 (VD), and retinoic acid (RA) induce differentiation of human monoblastic leukemia U937 cells to macrophage-like cells with potential superoxide anion-generating activity upon further stimulation. Here we report that U937 cells thus differentiated show various responses to apoptotic induction with a cytotoxic anti-Fas antibody and tumor necrosis factor (TNF), VD-or RA-treated U937 cells acquired resistance against Fas- or TNF receptor (TNFR)-mediated apoptosis, whereas apoptotic cell death was accelerated in IFN-gamma-treated cells, By flow cytometric analyses, no decrease in expression of surface Fas antigen or p55 TNFR was observed in differentiated U937 cells, Cell surface expression of CD11b was seen only when differentiation was induced with VD or RA but not with IFN-gamma, The growth of VD- or RA-treated cells was retarded but IFN-gamma-treated cells were prolific, These findings suggest that the differentiation state differs with the inducer and that the cellular response to apoptotic induction is closely related to the state including the cell cycle.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 49 条
  • [21] INHIBITION OF TUMOR-NECROSIS-FACTOR ALPHA-INDUCED AND CERAMIDE-INDUCED INTERNUCLEOSOMAL DNA FRAGMENTATION BY HERBIMYCIN A IN U937 CELLS
    JI, L
    ZHANG, G
    HIRABAYASHI, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 212 (02) : 640 - 647
  • [22] RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND INTERLEUKIN-1 (IL-1-BETA) AFTER PHORBOL ERSTER-INDUCED DIFFERENTIATION OF U937 CELLS
    HASS, R
    LONNEMANN, G
    KOHLER, L
    GOPPELTSTRUBE, M
    RESCH, K
    IMMUNOBIOLOGY, 1988, 178 (1-2) : 93 - 93
  • [24] EFFECT OF RETINOIC ACID AND VITAMIN-D ON THE EXPRESSION OF INTERLEUKIN-1-BETA, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN THE HUMAN MONOCYTIC CELL-LINE U937
    TAIMI, M
    DEFACQUE, H
    COMMES, T
    FAVERO, J
    CARON, E
    MARTI, J
    DORNAND, J
    IMMUNOLOGY, 1993, 79 (02) : 229 - 235
  • [25] PRODUCTION OF TRANSFORMING GROWTH-FACTOR-ALPHA BY HUMAN LEUKEMIA-CELLS (HL-60 AND U-937) DURING MONOCYTIC DIFFERENTIATION
    WALZ, TM
    MALM, C
    NISHIKAWA, BK
    WILLANDER, K
    WINGREN, S
    WASTESON, A
    LEUKEMIA, 1995, 9 (04) : 671 - 676
  • [26] IL-6 INHIBITS LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR PRODUCTION IN CULTURED HUMAN-MONOCYTES, U937 CELLS, AND IN MICE
    ADERKA, D
    LE, JM
    VILCEK, J
    JOURNAL OF IMMUNOLOGY, 1989, 143 (11): : 3517 - 3523
  • [27] THE ROLE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR AND NF-KAPPA-B IN HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN PROMONOCYTIC U937 CELLS
    BISWAS, P
    POLI, G
    FRANZOSO, G
    SIEBENLIST, U
    FAUCI, AS
    CLINICAL RESEARCH, 1993, 41 (02): : A244 - A244
  • [28] ENDOGENOUS TUMOR-NECROSIS-FACTOR AND NF-KAPPA-B REGULATE HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN PROMONOCYTIC U937 CELLS
    BISWAS, P
    POLI, G
    FRANZOSO, G
    SIEBENLIST, U
    FAUCI, AS
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A297 - A297
  • [29] 2-DEOXY-D-GLUCOSE ENHANCES SENSITIVITY OF HUMAN HISTIOCYTIC LYMPHOMA U937 CELLS TO APOPTOSIS INDUCED BY TUMOR-NECROSIS-FACTOR
    HALICKA, HD
    ARDELT, B
    LI, X
    MELAMED, MM
    DARZYNKIEWICZ, Z
    CANCER RESEARCH, 1995, 55 (02) : 444 - 449
  • [30] Gamma-interferon (IFN-γ) augments apoptotic response to mistletoe lectin-II via upregulation of Fas/Fas L expression and caspase activation in human myeloid U937 cells
    Kim, MS
    Lee, J
    So, HS
    Lee, KM
    Jung, BH
    Chung, SY
    Moon, SR
    Kim, NS
    Ko, CB
    Kim, HJ
    Kim, YK
    Park, R
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2001, 23 (01) : 55 - 66